Actively Recruiting
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
Led by David Sheyn · Updated on 2025-08-17
100
Participants Needed
1
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Interstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/ or discomfort associated with urinary frequency and urgency. The primary objective of this study is to determine the efficacy of amniotic membrane therapy in patients with interstitial cystitis/painful bladder syndrome (IC/PBS) as defined by clinically-significant improvement in validated symptom questionnaires.
CONDITIONS
Official Title
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years of age or older
- Female
- English speaking
- Diagnosis of interstitial cystitis/painful bladder syndrome (IC/PBS)
- Have failed at least one prior treatment for IC/PBS
You will not qualify if you...
- Patients less than 18 years of age
- Unable to provide consent
- Non-English speaking
- Known anatomical malformations of the ureters, bladder, or urethra
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospitals
Clevleand, Ohio, United States, 44106
Actively Recruiting
Research Team
M
Margot Le Neveu, MD
CONTACT
D
David Sheyn, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here